fbpx
Skip to main content
1/22/2018

iCureCeliac® Reports Two Year Progress

Launched in February 2016, iCureCeliac® is a free online portal for patients, or their caregivers, to provide critical insights into life with celiac disease and gluten/wheat sensitivity. Anonymized questionnaire data, completed by iCureCeliac® participants under informed consent, are made available to researchers and governmental policy analysts to advance life-changing initiatives. Your participation will help create better diagnostic tools and treatments…

Continue Reading
1/11/2018

New Testing Option for Possible Celiac Disease Sufferers

The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free…

Continue Reading
1/5/2018

New Testing Option for Possible Celiac Disease Sufferers

The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free…

Continue Reading
1/2/2018

How More Participation in Drug Trials Can Create Medical Breakthroughs, As Featured in USA Today

The Celiac Disease Foundation works tirelessly year-round to advance research toward treatments and a cure. Access to patient data is necessary to better target treatments for those with celiac disease. In the Foundation’s recent article featured in the December 2017 issue of Media Planet’s Digestive Health campaign of USA Today, titled “How More Participation in…

Continue Reading